Connect with us

Technology

Invest Smart, Grow Fast! Industries with Up to 20% Annual Growth

Published

on

“Discover High-Growth Opportunities Across Leading Sectors, With BCC Research Highlighting Industries Primed for Up to 20% Annual Returns”

BOSTON, Oct. 30, 2024 /PRNewswire/ — CAGR offers a clear view of long-term investment trends by balancing fluctuations for a steady growth rate. BCC Research reveals exciting growth opportunities, with specific industries poised for notable expansion—ideal for investors and stakeholders looking ahead.

1.  Zero Net Energy Buildings: Global Markets The global market for Zero Net Energy Buildings (ZNEBs) – which produce as much energy as they consume – is experiencing rapid growth. In 2022, the market size was $42.8 billion, but it’s expected to more than double to $109.2 billion by 2027. This represents an impressive annual growth rate of 20.6% over the next five years. As concern for climate change and energy efficiency continues to rise, the demand for ZNEBs is surging, driving innovation and investment in this sustainable and forward-thinking industry.

Microsoft: Microsoft’s Silicon Valley campus features a ZNEB design, with a focus on energy efficiency, renewable energy, and sustainable materials. The campus includes features like solar panels, green roofs, and advanced energy management systems to minimize energy consumption.Walgreens: Walgreens’ net-zero energy store in Evanston, Illinois, is a prime example of ZNEB in retail. The store features solar panels, wind turbines, and geothermal energy systems to power its operations. The building is designed to produce as much energy as it consumes over the course of a year.

2.  RNAi Drug Delivery: Technologies and Global Markets  The market for delivering RNA interference (RNAi) drugs, which use genetic material to treat diseases, is growing rapidly. Currently valued at $1.1 billion, it’s expected to nearly triple to $2.7 billion by 2028, with a remarkable annual growth rate of 20.5%. This surge is driven by advancements in technologies that help get these drugs into the body effectively, opening new possibilities for treating a range of medical conditions. As research and development continue to improve, the potential for RNAi drugs to revolutionize healthcare is vast, making this an exciting and promising field.

Alnylam Pharmaceuticals: Alnylam is a leading developer of RNAi therapeutics, with several approved treatments for rare genetic diseases. Their technology uses lipid nanoparticles to deliver RNAi drugs to specific cells, silencing disease-causing genes.Arrowhead Pharmaceuticals: Arrowhead is another prominent player in RNAi drug delivery, with a focus on developing treatments for liver and cardiovascular diseases. Their proprietary Targeted RNAi Molecule (TRiM) technology enables precise delivery of RNAi drugs to specific cells, reducing off-target effects.

3.  Biologics Development and Manufacturing Testing: Technologies and Global Markets The market for testing the safety of biologics, which are complex medicines made from living cells, is growing rapidly. Currently valued at $7.4 billion, it’s expected to more than double to $18.2 billion by 2027, with an impressive annual growth rate of 19.9%. This surge is driven by the increasing demand for biologics to treat various diseases, and the need for rigorous testing to ensure their safety and effectiveness. As biologics become more prevalent in healthcare, the importance of thorough testing and quality control grows, making this a critical and expanding field.

Pfizer: Pfizer, a global pharmaceutical giant, uses advanced biologics safety testing technologies to ensure the quality and efficacy of its biologic medicines. Their testing protocols include state-of-the-art analytical techniques, such as mass spectrometry and chromatography, to detect impurities and ensure product consistency.Biogen: Biogen, a leading biotechnology company, employs rigorous biologics safety testing methods to develop and manufacture innovative treatments for complex diseases. Their testing strategies include cutting-edge technologies like next-generation sequencing and advanced bioinformatics to identify potential safety risks and optimize product development.

4.  Viral Vector and Plasmid DNA: Technologies and Global Markets The market for viral vector and plasmid DNA technologies, which are crucial tools for developing gene therapies and vaccines, is experiencing rapid growth. Currently valued at $2.9 billion, it’s expected to more than double to $7.1 billion by 2028, with an impressive annual growth rate of 19.7%. This surge is driven by the increasing demand for innovative treatments for genetic diseases and infectious diseases, as well as advancements in technologies that enable precise gene editing and delivery. As researchers and companies continue to harness the power of genetic medicine, the demand for these technologies is skyrocketing, making this a dynamic and promising field.

Moderna Therapeutics: Moderna, a pioneering biotech company, uses viral vector technology to develop innovative mRNA-based vaccines and therapies. Their platform leverages a type of viral vector called lipid nanoparticles to deliver genetic material to cells, instructing them to produce specific proteins.Spark Therapeutics: Spark Therapeutics, a leading gene therapy company, utilizes viral vectors to develop treatments for inherited diseases. Their technology employs adeno-associated virus (AAV) vectors to deliver healthy copies of a gene to cells, replacing faulty or missing genes that cause disease.

5.  Inkjet Printing Technologies: Applications and Asia-Pacific Markets The market for inkjet printing technologies in the Asia-Pacific region is booming! Currently valued at $7.4 billion, it’s expected to more than double to $18.2 billion by 2028, growing at an impressive rate of 19.6% each year. This surge is driven by increasing demand for high-quality printing in various industries, such as textiles, ceramics, and packaging. Advancements in inkjet technology have made it faster, more precise, and cost-effective, making it an attractive option for businesses looking to enhance their printing capabilities. As a result, the Asia-Pacific market is poised for significant growth, with new opportunities emerging for companies that adopt this innovative technology.

Epson: Epson, a renowned electronics company, utilizes inkjet printing technology in its wide-format printers for various applications, including signage, textiles, and ceramics. Their proprietary Micro Piezo printheads enable precise droplet control, resulting in high-quality prints.Canon: Canon, a leading imaging and optical products company, employs inkjet printing technology in its production printers for high-speed, high-quality printing. Their inkjet technology is used in various industries, including commercial printing, packaging, and labels, offering efficient and reliable printing solutions.

6.  Global Electrical Vehicle Battery Market The market for electric vehicle (EV) batteries is rapidly accelerating! Was valued at $66.4 billion, it’s expected to nearly triple to $161.3 billion by 2028, growing at an impressive rate of 19.4% each year. This surge is driven by the increasing adoption of electric vehicles, government initiatives promoting sustainable transportation, and advancements in battery technology. As EVs become more mainstream, the demand for high-performance, efficient, and cost-effective batteries is skyrocketing, making this market a hotbed of innovation and growth. With major players investing heavily in research and development, the future of EV batteries looks bright and electrifying!

Tesla: Tesla, a pioneering electric vehicle manufacturer, designs and produces its own EV batteries, including the popular Lithium-Ion battery cells. Their battery technology powers their entire range of electric vehicles, including the Model S, Model 3, and Model Y.LG Chem: LG Chem, a leading chemical and battery manufacturer, supplies EV batteries to several major automotive companies, including General Motors, Ford, and Hyundai. Their advanced battery technology, including Lithium-Ion and Nickel-Manganese-Cobalt (NMC) batteries, enables efficient and reliable EV performance.

7.  Next-generation Sequencing: Emerging Clinical Applications and Global Markets The market for next-generation sequencing (NGS) in clinical settings is experiencing rapid growth! Currently valued at $21.9 billion, it’s expected to more than double to $52.9 billion by 2028, with an impressive annual growth rate of 19.3%. This surge is driven by the increasing adoption of NGS in healthcare, enabling precise diagnosis, personalized treatment, and targeted therapies. NGS technology allows for rapid and cost-effective analysis of genetic data, revolutionizing fields like oncology, infectious diseases, and rare genetic disorders. As a result, the demand for NGS in clinical applications is skyrocketing, transforming the way we approach patient care and treatment.

Illumina: Illumina, a leading biotechnology company, develops and markets NGS systems, including the popular HiSeq and NovaSeq platforms. Their technology enables rapid and accurate genetic analysis, driving advancements in cancer research, rare disease diagnosis, and personalized medicine.Thermo Fisher Scientific: A global life sciences company, Thermo Fisher Scientific offers a range of NGS solutions, including the Ion Torrent and Applied Biosystems platforms. Their technology supports various clinical applications, such as noninvasive prenatal testing, cancer profiling, and infectious disease detection.

8.  Global 5G Chipset Market The market for 5G chipsets is growing rapidly! In 2022, it was valued at $26.1 billion, and it’s expected to increase to $30 billion by 2023 and then more than double to $72 billion by 2028, with an impressive annual growth rate of 19.1%. This surge is driven by the increasing demand for high-speed, low-latency connectivity in various industries, including smartphones, laptops, and emerging technologies like autonomous vehicles and smart cities. As 5G networks continue to expand globally, the need for advanced chipsets that enable fast and reliable data transfer is skyrocketing, making this market a hotbed of innovation and growth.

Qualcomm: Qualcomm, a leading semiconductor company, designs and manufactures 5G chipsets, including the popular Snapdragon series, which powers many smartphones and laptops. Their 5G chipsets enable fast data transfer, low latency, and improved connectivity.Mediatek: Mediatek, a Taiwanese semiconductor company, produces 5G chipsets for various applications, including smartphones, tablets, and smart home devices. Their 5G chipsets offer high-speed connectivity, power efficiency, and advanced features like AI processing.

Get ready for a revolution! The explosive growth in emerging technologies like viral vectors, inkjet printing, electric vehicle batteries, next-generation sequencing, and 5G chipsets is transforming industries and creating unprecedented opportunities. As these markets soar, businesses and investors can expect a thrilling ride of innovation, sustainability, and boundless potential. Buckle up and join the journey to a brighter, more connected, and more sustainable future!

For further information or to make a purchase, please get in touch with info@bccresearch.com.

About BCC Research

BCC Research provides objective, unbiased measurement, and assessment of market opportunities with detailed market research reports. Our experienced industry analysts’ goal is to help you make informed business decisions, free of noise and hype.

Contact Us
Corporate HQ: 50 Milk St. Ste 16, Boston, MA 02109, USA
Email: info@bccresearch.com,
Phone: +1 781-489-7301

For media inquiries, email press@bccresearch.com or visit our media page for access to our market research library.

Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher.

Logo: https://mma.prnewswire.com/media/2183242/BCC_Research_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/invest-smart-grow-fast-industries-with-up-to-20-annual-growth-302292013.html

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Fangzhou Inc. Garners Industry Recognition as an Innovator in AI Technology

Published

on

By

GUANGZHOU, China, Oct. 30, 2024 /PRNewswire/ — Fangzhou Inc. (“Fangzhou”) (06086.HK), a leader in Internet healthcare solutions, was featured on the 2024 Guangdong “AI Catalyst” Enterprise Billboard at the 2024 Guangdong-Hong Kong-Macao Greater Bay Area Artificial Intelligence Industry Conference. The Company was selected for its significant contributions in advancing the use of AI technology in the field of online healthcare and chronic disease management. Fangzhou’s platform leverages advanced technologies, including AI assistants and big data, with the goal of enhancing the efficiency of its chronic disease management services and providing patients and doctors with a better user experience.

Mr. Xie Fangmin, CEO of Fangzhou, stated, “We are honored to be recognized as an AI technology innovator. This acknowledgment reflects our commitment to improving healthcare through technological advancement and our dedication to providing exceptional service to patients and healthcare providers alike.”

Guangdong at the Forefront of AI Integration

Guangdong has consistently demonstrated its commitment to fostering AI applications across a range of industries and sectors. In May, it introduced the “Measures for Empowering Various Industries with Artificial Intelligence,” aiming to create over 500 AI-driven application scenarios in areas like manufacturing, education, and senior care. This effort continued in October with the “Action Plan for Promoting High-Quality Development of Guangdong’s Life Sciences Industry,” outlining 38 measures to position Guangdong as a leading biotech hub.

About Fangzhou Inc.

Fangzhou Inc. (06086.HK) is China’s leading online chronic disease management platform. With 45.6 million registered users and 217,000 registered doctors on its platform (as of June 30, 2024), the Company provides tailored medical care and precision medicine for a growing population of chronic disease patients. For more details, visit https://investors.jianke.com.

About the Greater Bay Area Artificial Intelligence Industry Conference

The 2024 Guangdong-Hong Kong-Macao Greater Bay Area Artificial Intelligence Industry Conference was held on October 23rd in Nansha, Guangzhou. Under the leadership of the Guangdong Province Department of Science and Technology, the event was organized by the Guangdong Association of Artificial Intelligence Industry, with support from the Smart Manufacturing Committee of the Chinese Association for Artificial Intelligence and Guangzhou University. The conference gathered 11 prominent academicians and over 1,000 leaders from academia and industry to explore AI trends and technological advancements.

Disclaimer: This press release contains forward-looking statements. Actual results may differ materially from those anticipated due to various factors. Readers are cautioned not to place undue reliance on these statements

Media Contact
For further inquiries or interviews, please reach out to:
Xingwei Zhao Associate Director of Public Relations Email: pr@jianke.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/fangzhou-inc-garners-industry-recognition-as-an-innovator-in-ai-technology-302292293.html

SOURCE Fangzhou Inc.

Continue Reading

Technology

EQT Acquires Leading SaaS Talent Solutions Provider PageUp to Accelerate Global Expansion and Product Innovation

Published

on

By

PageUp will leverage EQT’s expertise to accelerate international expansion and drive product innovation in talent management software.EQT’s investment builds on PageUp’s strong track record of expansion through organic growth and strategic acquisitions.The partnership reinforces EQT’s commitment to supporting high-growth software businesses in Asia Pacific and international markets.

STOCKHOLM, Oct. 31, 2024 /PRNewswire/ — EQT and PageUp Group today announced that EQT, a purpose-driven global investment organization, has acquired Australian-founded PageUp, a global leader in SaaS talent acquisition, recruitment marketing, and talent management solutions from existing majority owners, Battery Ventures.

The deal will enable PageUp to leverage EQT’s deep expertise in scaling high-growth global technology businesses to capture greater opportunities in the talent management software space, accelerate its international expansion, and enhance product innovation.

Founded in 1997, PageUp now delivers its cutting-edge talent acquisition and recruitment marketing software to top-tier corporates, universities, hospitals, and public-sector customers worldwide via offices in Australia, North America, and Europe. PageUp’s product suite powers the end-to-end talent management of global brands such as Flight Centre Travel Group, Ramsay Healthcare Australia, Bank of Ireland, Boston Medical Centre, and University of North Texas Systems.

EQT’s investment, through its BPEA Fund VIII (“EQT Private Capital Asia”), builds on PageUp’s operating momentum in achieving substantial organic and acquisition-led growth in recent years. This has included the acquisitions of Clinch in 2019 and eArcu and PathMotion in 2021. With EQT’s investment and strategic backing, PageUp will accelerate its expansion into priority international markets and deepen its offering in key sectors and verticals.

PageUp represents EQT’s latest investment in the Human Capital Management (“HCM”) software sector, which it views as an attractive and dynamic segment as HR professionals leverage technology to meet the challenges of attracting and retaining an evolving global workforce. PageUp adds to EQT’s global portfolio of investments in HCM software businesses across strategies, which includes Peakon, Unmind, Hume, Sana Labs, and HRBrain.

The investment further builds on EQT’s experience supporting market-leading Asia Pacific-based software businesses to capture global market opportunities. EQT will work with PageUp to construct a board of HR technology veterans from members of EQT’s industrial advisor network, pursue targeted inorganic growth opportunities in key markets worldwide, and accelerate the company’s AI product roadmap with help from EQT Digital.

Nicholas Macksey, Partner in the EQT Private Capital Asia advisory team, said: “PageUp’s impressive track record of innovation and growth makes it a standout leader in the talent management space. We are excited to partner with PageUp at this defining moment for the company. We look forward to leveraging EQT’s global reach and sector expertise to accelerate PageUp’s international expansion and amplify its product innovation, particularly in dynamic, high-growth markets. As the human capital management landscape rapidly evolves, we are committed to helping PageUp unlock new opportunities for its clients worldwide. This investment reinforces EQT’s strength in supporting software businesses that align with our core investment themes, allowing us to apply our deep expertise to foster innovation and drive impact in key industries.”

Following the successful completion of the transaction, Mark Rice has announced his intention to retire as CEO of PageUp. Over 13 years (initially as COO/CFO and as CEO for the last six years), Mark has led the Group’s dynamic and profitable growth and driven its international expansion both organically and through several successful acquisitions.

Commenting on the successful acquisition and his decision to retire as CEO, PageUp Group’s outgoing CEO Mark Rice said: “EQT’s investment is a ringing endorsement of our business and the significant opportunities for market and product expansion ahead. After 13 years leading the business, and with EQT’s investment now secured, I have decided that now is the right time for me to retire as CEO, safe in the knowledge the company I have helped build is in safe hands. I am immensely proud of what we have accomplished at PageUp as a team and this decision was made easier knowing the business is well-positioned with supportive partners for its next phase of growth.”

Mark will oversee a transition period with incoming CEO Eric Lochner. Eric has over 25 years of leadership experience scaling SaaS companies globally, most notably HR Tech companies Kenexa, Achievers, and Careerbuilder.com. Eric Lochner said: “Under Mark’s stewardship, PageUp has gone from strength to strength. I am delighted to have accepted the opportunity to step into the CEO role and look forward to working with our new partners in transforming our clients’ hiring experiences and empowering individuals to find opportunities where they are happy, engaged, and fulfilled. With EQT’s expertise and support, we’ll accelerate our strategy with increased focus on customer experience and innovation, including the continued integration of responsible AI to rapidly evolve our platform and enhance the automation of talent management.”

William Blair acted as the exclusive financial advisor to PageUp Group on this transaction. Barclays and Barrenjoey acted as the exclusive financial advisor to EQT on this transaction. 

With this transaction, BPEA Private Equity Fund VIII is expected to be 80-90 percent invested (including closed and/or signed investments, announced public offers, if applicable, and less any expected syndication) based on target fund size and subject to customary regulatory approvals.

The information contained herein does not constitute an offer to sell, nor a solicitation of an offer to buy, any security and may not be used or relied upon in connection with any offer or solicitation. Any offer or solicitation in respect of BPEA Private Equity Fund VIII will be made only through a confidential private placement memorandum and related documents which will be furnished to qualified investors on a confidential basis in accordance with applicable laws and regulations. The information contained herein is not for publication or distribution to persons in the United States of America. Any securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the “Securities Act”), and may not be offered or sold without registration thereunder or pursuant to an available exemption therefrom. Any offering of securities to be made in the United States would have to be made by means of an offering document that would be obtainable from the issuer or its agents and would contain detailed information about the issuer of the securities and its management, as well as financial information. The securities may not be offered or sold in the United States absent registration or an exemption from registration.

Contact
EQT Press Office, press@eqtpartners.com

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/eqt/r/eqt-acquires-leading-saas-talent-solutions-provider-pageup-to-accelerate-global-expansion-and-produc,c4059322

The following files are available for download:

https://mb.cision.com/Main/87/4059322/3086631.pdf

241031 Press Release_EQT Acquires Leading SaaS Talent Solutions Provider PageUp to Accelerate Global Expansion and Product Innovation

https://news.cision.com/eqt/i/pageup-team,c3347681

PageUp Team

 

View original content:https://www.prnewswire.co.uk/news-releases/eqt-acquires-leading-saas-talent-solutions-provider-pageup-to-accelerate-global-expansion-and-product-innovation-302292300.html

Continue Reading

Technology

AIKO Showcases its High-Efficiency N-type ABC Modules at All Energy Australia

Published

on

By

MELBOURNE, Australia, Oct. 31, 2024 /PRNewswire/ — AIKO made an impactful debut at Melbourne’s premier energy event, All Energy Australia, which kicked off on October 23, 2024, in Melbourne. The company showcased its comprehensive range of high-efficiency N-type ABC modules, including the latest N-type ABC INFINITE technology and the Neostar Series 475W modules. These products garnered considerable attention from international visitors and customers, highlighting AIKO’s commitment to pioneering energy-efficient solutions.

Specifically designed for the Australian market, AIKO’s Neostar 2P module offers an impressive 475W power output, making it the highest-power 54-cell commercial module available locally, all within a footprint of less than two square meters. The exceptional conversion efficiency ensures maximum power in a limited space, a significant advantage for AIKO’s N-type ABC products in the Australian market, especially for residential applications.

AIKO’s N-type ABC modules have now achieved a mass production efficiency of 24.2%, topping the TaiyangNews Global Commercial Module Mass Production Efficiency Rankings for 20 consecutive months. The third-generation INFINITE N-type ABC module on display at the event boasts an efficiency of over 25%. Its unique 0BB technology, overlapped welding, and concealed busbar configuration optimizes light capture while enhancing visual appeal, drawing significant interest from attendees.

AIKO Australia and New Zealand Country Director Thomas Bywater remarked, “AIKO is steadfastly customer-centric, dedicated to meeting current market demands and exploring innovative solutions for future needs. Our high-efficiency products, such as the Neostar 475W and INFINITE modules, reinforce our commitment to advancing efficiency and sustainability in the Australian PV market.”

At the exhibition, AIKO demonstrated the superior performance of its N-type ABC modules over traditional technologies through a shadow power generation optimization and an anti-hidden crack comparison test.

Australia is home to the world’s most optimal solar resources, with over 80% of the land receiving solar radiation intensities exceeding 2000 kWh/m². According to BloombergNEF, 83% of Australia’s coal-fired power generation units are expected to be decommissioned by 2035, creating significant market potential for renewable energy. Looking ahead, AIKO will continue to maximize the conversion efficiency, driving product innovation and upgrades. AIKO’s cutting-edge technology and products are designed to significantly contribute to the global energy transition and provide robust support for a zero-carbon future.

 

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/aiko-showcases-its-high-efficiency-n-type-abc-modules-at-all-energy-australia-302292303.html

SOURCE Aiko

Continue Reading

Trending